Your browser doesn't support javascript.
loading
Prevalence of juvenile myoclonic epilepsy in people <30 years of age-A population-based study in Norway.
Syvertsen, Marte; Hellum, Morten Kristoffer; Hansen, Gunnar; Edland, Astrid; Nakken, Karl Otto; Selmer, Kaja Kristine; Koht, Jeanette.
Afiliação
  • Syvertsen M; Department of Neurology, Drammen Hospital, Vestre Viken Hospital Trust, Drammen, Norway.
  • Hellum MK; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Hansen G; Department of Neurology, Drammen Hospital, Vestre Viken Hospital Trust, Drammen, Norway.
  • Edland A; Department of Neurology, Drammen Hospital, Vestre Viken Hospital Trust, Drammen, Norway.
  • Nakken KO; Department of Neurology, Drammen Hospital, Vestre Viken Hospital Trust, Drammen, Norway.
  • Selmer KK; Division of Clinical Neuroscience, National Center for Epilepsy, Oslo University Hospital, Oslo, Norway.
  • Koht J; Department of Medical Genetics, Oslo University Hospital and University of Oslo, Oslo, Norway.
Epilepsia ; 58(1): 105-112, 2017 01.
Article em En | MEDLINE | ID: mdl-27861775
ABSTRACT

OBJECTIVE:

Despite juvenile myoclonic epilepsy (JME) being considered one of the most common epilepsies, population-based prevalence studies of JME are lacking. Our aim was to estimate the prevalence of JME in a Norwegian county, using updated diagnostic criteria.

METHODS:

This was a cross-sectional study, based on reviews of the medical records of all patients with a diagnosis of epilepsy at Drammen Hospital in the period 1999-2013. The study population consisted of 98,152 people <30 years of age. Subjects diagnosed with JME, unspecified genetic generalized epilepsy, or absence epilepsy were identified. All of these patients were contacted and asked specifically about myoclonic jerks. Electroencephalography (EEG) recordings and medical records were reevaluated for those who confirmed myoclonic jerks. Information about seizure onset was obtained from the medical records, and annual frequency of new cases was estimated.

RESULTS:

A total of 55 subjects fulfilled the diagnostic criteria for JME. The point prevalence was estimated at 5.6/10,000. JME constituted 9.3% of all epilepsies in the age group we investigated. Of subjects diagnosed with either unspecified genetic generalized epilepsy or absence epilepsy, 21% and 12%, respectively, had JME. We identified 21 subjects with JME (38%) who had not been diagnosed previously. Six subjects (11%) had childhood absence epilepsy evolving into JME. Between 2009 and 2013, the average frequency of JME per 100,000 people of all ages per year was estimated at 1.7.

SIGNIFICANCE:

A substantial portion of people with JME seem to go undiagnosed, as was the case for more than one third of the subjects in this study. By investigating subjects diagnosed with unspecified genetic generalized epilepsy or absence epilepsy, we found a prevalence of JME that was considerably higher than previously reported. We conclude that JME may go undiagnosed due to the underrecognition of myoclonic jerks. To make a correct diagnosis, clinicians need to ask specifically about myoclonic jerks.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Female / Humans / Male País/Região como assunto: Europa Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Female / Humans / Male País/Região como assunto: Europa Idioma: En Ano de publicação: 2017 Tipo de documento: Article